The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis

Yoshiteru Miyauchi, Ken Ninomiya, Hiroya Miyamoto, Akemi Sakamoto, Ryotaro Iwasaki, Hiroko Hoshi, Kana Miyamoto, Wu Hao, Shigeyuki Yoshida, Hideo Morioka, Kazuhiro Chiba, Shigeaki Kato, Takeshi Tokuhisa, Mitinori Saitou, Yoshiaki Toyama, Toshio Suda, Takeshi Miyamoto

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Controlling osteoclastogenesis is critical to maintain physiological bone homeostasis and prevent skeletal disorders. Although signaling activating nuclear factor of activated T cells 1 (NFATc1), a transcription factor essential for osteoclastogenesis, has been intensively investigated, factors antagonistic to NFATc1 in osteoclasts have not been characterized. Here, we describe a novel pathway that maintains bone homeostasis via two transcriptional repressors, B cell lymphoma 6 (Bcl6) and B lymphocyte-induced maturation protein-1 (Blimp1). We show that Bcl6 directly targets 'osteoclastic' molecules such as NFATc1, cathepsin K, and dendritic cell-specific transmembrane protein (DC-STAMP), all of which are targets of NFATc1. Bcl6-overexpression inhibited osteoclastogenesis in vitro, whereas Bcl6-deficient mice showed accelerated osteoclast differentiation and severe osteoporosis. We report that Bcl6 is a direct target of Blimp1 and that mice lacking Blimp1 in osteoclasts exhibit osteopetrosis caused by impaired osteoclastogenesis resulting from Bcl6 up-regulation. Indeed, mice doubly mutant in Blimp1 and Bcl6 in osteoclasts exhibited decreased bone mass with increased osteoclastogenesis relative to osteoclast-specific Blimp1-deficient mice. These results reveal a Blimp1-Bcl6-osteoclastic molecule axis, which critically regulates bone homeostasis by controlling osteoclastogenesis and may provide a molecular basis for novel therapeutic strategies.

Original languageEnglish
Pages (from-to)751-762
Number of pages12
JournalJournal of Experimental Medicine
Volume207
Issue number4
DOIs
Publication statusPublished - 2010 Apr 12

Fingerprint

Proto-Oncogene Proteins c-bcl-6
B-Cell Lymphoma
Osteoclasts
Osteogenesis
NFATC Transcription Factors
Homeostasis
B-Lymphocytes
Bone and Bones
Cathepsin K
Osteopetrosis
Proteins
Dendritic Cells
Osteoporosis
Transcription Factors
Up-Regulation

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Miyauchi, Y., Ninomiya, K., Miyamoto, H., Sakamoto, A., Iwasaki, R., Hoshi, H., ... Miyamoto, T. (2010). The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. Journal of Experimental Medicine, 207(4), 751-762. https://doi.org/10.1084/jem.20091957

The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. / Miyauchi, Yoshiteru; Ninomiya, Ken; Miyamoto, Hiroya; Sakamoto, Akemi; Iwasaki, Ryotaro; Hoshi, Hiroko; Miyamoto, Kana; Hao, Wu; Yoshida, Shigeyuki; Morioka, Hideo; Chiba, Kazuhiro; Kato, Shigeaki; Tokuhisa, Takeshi; Saitou, Mitinori; Toyama, Yoshiaki; Suda, Toshio; Miyamoto, Takeshi.

In: Journal of Experimental Medicine, Vol. 207, No. 4, 12.04.2010, p. 751-762.

Research output: Contribution to journalArticle

Miyauchi, Y, Ninomiya, K, Miyamoto, H, Sakamoto, A, Iwasaki, R, Hoshi, H, Miyamoto, K, Hao, W, Yoshida, S, Morioka, H, Chiba, K, Kato, S, Tokuhisa, T, Saitou, M, Toyama, Y, Suda, T & Miyamoto, T 2010, 'The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis', Journal of Experimental Medicine, vol. 207, no. 4, pp. 751-762. https://doi.org/10.1084/jem.20091957
Miyauchi, Yoshiteru ; Ninomiya, Ken ; Miyamoto, Hiroya ; Sakamoto, Akemi ; Iwasaki, Ryotaro ; Hoshi, Hiroko ; Miyamoto, Kana ; Hao, Wu ; Yoshida, Shigeyuki ; Morioka, Hideo ; Chiba, Kazuhiro ; Kato, Shigeaki ; Tokuhisa, Takeshi ; Saitou, Mitinori ; Toyama, Yoshiaki ; Suda, Toshio ; Miyamoto, Takeshi. / The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. In: Journal of Experimental Medicine. 2010 ; Vol. 207, No. 4. pp. 751-762.
@article{8979099159204f459eebba30e4691950,
title = "The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis",
abstract = "Controlling osteoclastogenesis is critical to maintain physiological bone homeostasis and prevent skeletal disorders. Although signaling activating nuclear factor of activated T cells 1 (NFATc1), a transcription factor essential for osteoclastogenesis, has been intensively investigated, factors antagonistic to NFATc1 in osteoclasts have not been characterized. Here, we describe a novel pathway that maintains bone homeostasis via two transcriptional repressors, B cell lymphoma 6 (Bcl6) and B lymphocyte-induced maturation protein-1 (Blimp1). We show that Bcl6 directly targets 'osteoclastic' molecules such as NFATc1, cathepsin K, and dendritic cell-specific transmembrane protein (DC-STAMP), all of which are targets of NFATc1. Bcl6-overexpression inhibited osteoclastogenesis in vitro, whereas Bcl6-deficient mice showed accelerated osteoclast differentiation and severe osteoporosis. We report that Bcl6 is a direct target of Blimp1 and that mice lacking Blimp1 in osteoclasts exhibit osteopetrosis caused by impaired osteoclastogenesis resulting from Bcl6 up-regulation. Indeed, mice doubly mutant in Blimp1 and Bcl6 in osteoclasts exhibited decreased bone mass with increased osteoclastogenesis relative to osteoclast-specific Blimp1-deficient mice. These results reveal a Blimp1-Bcl6-osteoclastic molecule axis, which critically regulates bone homeostasis by controlling osteoclastogenesis and may provide a molecular basis for novel therapeutic strategies.",
author = "Yoshiteru Miyauchi and Ken Ninomiya and Hiroya Miyamoto and Akemi Sakamoto and Ryotaro Iwasaki and Hiroko Hoshi and Kana Miyamoto and Wu Hao and Shigeyuki Yoshida and Hideo Morioka and Kazuhiro Chiba and Shigeaki Kato and Takeshi Tokuhisa and Mitinori Saitou and Yoshiaki Toyama and Toshio Suda and Takeshi Miyamoto",
year = "2010",
month = "4",
day = "12",
doi = "10.1084/jem.20091957",
language = "English",
volume = "207",
pages = "751--762",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "4",

}

TY - JOUR

T1 - The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis

AU - Miyauchi, Yoshiteru

AU - Ninomiya, Ken

AU - Miyamoto, Hiroya

AU - Sakamoto, Akemi

AU - Iwasaki, Ryotaro

AU - Hoshi, Hiroko

AU - Miyamoto, Kana

AU - Hao, Wu

AU - Yoshida, Shigeyuki

AU - Morioka, Hideo

AU - Chiba, Kazuhiro

AU - Kato, Shigeaki

AU - Tokuhisa, Takeshi

AU - Saitou, Mitinori

AU - Toyama, Yoshiaki

AU - Suda, Toshio

AU - Miyamoto, Takeshi

PY - 2010/4/12

Y1 - 2010/4/12

N2 - Controlling osteoclastogenesis is critical to maintain physiological bone homeostasis and prevent skeletal disorders. Although signaling activating nuclear factor of activated T cells 1 (NFATc1), a transcription factor essential for osteoclastogenesis, has been intensively investigated, factors antagonistic to NFATc1 in osteoclasts have not been characterized. Here, we describe a novel pathway that maintains bone homeostasis via two transcriptional repressors, B cell lymphoma 6 (Bcl6) and B lymphocyte-induced maturation protein-1 (Blimp1). We show that Bcl6 directly targets 'osteoclastic' molecules such as NFATc1, cathepsin K, and dendritic cell-specific transmembrane protein (DC-STAMP), all of which are targets of NFATc1. Bcl6-overexpression inhibited osteoclastogenesis in vitro, whereas Bcl6-deficient mice showed accelerated osteoclast differentiation and severe osteoporosis. We report that Bcl6 is a direct target of Blimp1 and that mice lacking Blimp1 in osteoclasts exhibit osteopetrosis caused by impaired osteoclastogenesis resulting from Bcl6 up-regulation. Indeed, mice doubly mutant in Blimp1 and Bcl6 in osteoclasts exhibited decreased bone mass with increased osteoclastogenesis relative to osteoclast-specific Blimp1-deficient mice. These results reveal a Blimp1-Bcl6-osteoclastic molecule axis, which critically regulates bone homeostasis by controlling osteoclastogenesis and may provide a molecular basis for novel therapeutic strategies.

AB - Controlling osteoclastogenesis is critical to maintain physiological bone homeostasis and prevent skeletal disorders. Although signaling activating nuclear factor of activated T cells 1 (NFATc1), a transcription factor essential for osteoclastogenesis, has been intensively investigated, factors antagonistic to NFATc1 in osteoclasts have not been characterized. Here, we describe a novel pathway that maintains bone homeostasis via two transcriptional repressors, B cell lymphoma 6 (Bcl6) and B lymphocyte-induced maturation protein-1 (Blimp1). We show that Bcl6 directly targets 'osteoclastic' molecules such as NFATc1, cathepsin K, and dendritic cell-specific transmembrane protein (DC-STAMP), all of which are targets of NFATc1. Bcl6-overexpression inhibited osteoclastogenesis in vitro, whereas Bcl6-deficient mice showed accelerated osteoclast differentiation and severe osteoporosis. We report that Bcl6 is a direct target of Blimp1 and that mice lacking Blimp1 in osteoclasts exhibit osteopetrosis caused by impaired osteoclastogenesis resulting from Bcl6 up-regulation. Indeed, mice doubly mutant in Blimp1 and Bcl6 in osteoclasts exhibited decreased bone mass with increased osteoclastogenesis relative to osteoclast-specific Blimp1-deficient mice. These results reveal a Blimp1-Bcl6-osteoclastic molecule axis, which critically regulates bone homeostasis by controlling osteoclastogenesis and may provide a molecular basis for novel therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=77951074209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951074209&partnerID=8YFLogxK

U2 - 10.1084/jem.20091957

DO - 10.1084/jem.20091957

M3 - Article

C2 - 20368579

AN - SCOPUS:77951074209

VL - 207

SP - 751

EP - 762

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 4

ER -